GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


CMAJ
CMAJ - April 4, 2000JAMC - le 4 avril 2000

To pay or not to pay? A decision and cost­utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy [Correction]

CMAJ 2000;162:973

Owing to a copyediting error, the affiliation information for one of the authors of a recent CMAJ article was published incorrectly.1 Susan Foster is with the London School of Hygiene and Tropical Medicine, which is affiliated with the University of London in Britain.

The online version is correct.

Reference

  1. Clark WF, Churchill DN, Forwell L, Macdonald G, Foster S. To pay or not to pay? A decision and cost­utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy. CMAJ 2000;162(2):195-8.

© 2000 Canadian Medical Association or its licensors